Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019

SELL
$19.17 - $27.4 $1.34 Million - $1.92 Million
-70,088 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$22.93 - $42.84 $252,230 - $471,240
11,000 Added 18.62%
70,088 $1.84 Million
Q1 2019

May 10, 2019

BUY
$32.69 - $47.91 $1.93 Million - $2.83 Million
59,088 New
59,088 $2.24 Million

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $872M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Fosun International LTD Portfolio

Follow Fosun International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fosun International LTD with notifications on news.